INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,663 | -94.6% | 58,260 | -93.8% | 0.00% | -100.0% |
| Q2 2023 | $421,581 | +30.4% | 944,190 | +139.5% | 0.00% | +100.0% |
| Q1 2023 | $323,301 | +94.8% | 394,270 | +310.1% | 0.00% | 0.0% |
| Q3 2022 | $166,000 | -53.6% | 96,137 | -53.5% | 0.00% | -66.7% |
| Q2 2022 | $358,000 | +302.2% | 206,767 | +735.8% | 0.00% | +200.0% |
| Q1 2022 | $89,000 | -79.5% | 24,738 | -71.6% | 0.00% | -66.7% |
| Q4 2021 | $434,000 | +1176.5% | 86,996 | +753.1% | 0.00% | +200.0% |
| Q4 2019 | $34,000 | – | 10,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |